Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 1

Interventions

cabozantinib 2Surveys and Questionnaires 2Ipilimumab 2Axitinib 2zimberelimab 1temsirolimus 1salicylhydroxamic acid 1orellanine 1brodalumab 1belzutifan 1atezolizumab 1Selenomethionine 1Ropivacaine 1Radionuclide Imaging 1Pluvicto 1Patient Reported Outcome Measures 1Methods 1Magnetic Resonance Imaging 1Health Promotion 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Everolimus 1Erlotinib Hydrochloride 1Educational Status 1Early Intervention, Educational 1Docetaxel 1Dacarbazine 1Counseling 1Blood Component Removal 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Selenomethionine × 30 days × Clear all
NCT02535533 2026-05-06

SLM + Axitinib for Clear Cell RCC

University of Iowa

Phase 1/2 Completed
45 enrolled 18 charts
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡